Your session is about to expire
← Back to Search
Baduanjin Exercise for Cognitive Decline (BDJ Trial)
BDJ Trial Summary
This trial looks at whether Baduanjin, a type of mind-body exercise, can improve cognitive function, brain connectivity, and brain structure in people with subjective cognitive decline.
BDJ Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowBDJ Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.BDJ Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- The Mini-Mental State Examination, Second Edition (MMSE-2) scores within the normal range.You have a history of severe mental health problems or intellectual disability since birth.My thinking and memory test scores are normal for my age, sex, and education level.You have previous experience practicing Baduanjin exercises.You have no memory loss or slight forgetfulness.I do not have conditions like stroke, brain injury, or Parkinson's affecting my thinking.I am between 50 and 80 years old.I have been diagnosed with depression.You have concerns about your memory.I cannot perform at least one daily task because of cognitive reasons.I have been diagnosed with mild cognitive impairment, Alzheimer's, or another type of dementia.I cannot commit to a 6-month study with an additional 3-month follow-up.You have noticed a decline in your memory over the past 5 years, and other people have also noticed the decline.
- Group 1: Baduanjin
- Group 2: Cognitive Fitness Program
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
To whom is this clinical trial open for enrollment?
"Eligibility for this trial requires the patient to be between 50 and 80 years old, as well as demonstrate cognitive decline. This clinical study is accepting around 120 recruits in total."
What is the size of the sample population participating in this experiment?
"Affirmative. Clinicaltrials.gov shows that this research is actively recruiting patients, having first been posted on August 31st 2020 and most recently updated on June 23rd 2021. The study needs to recruit 120 individuals from one medical centre."
Are any openings available for individuals wishing to participate in this clinical experiment?
"Affirmative. Clinicaltrials.gov lists this clinical trial as currently seeking participants; the study was initial posted on August 31st 2020, and revised most recently on June 23rd 2021. The research is hoping to enroll 120 individuals from 1 site."
What results are researchers hoping to achieve from this medical experiment?
"The purpose of this trial, which will be assessed at baseline, 3 months and 6 months is to determine the impact of exercise on Alzheimer Disease Cooperative Study- Preclinical Alzheimer (ADCS-PACC) Cognitive Composite. Secondary aims include measuring changes in brain grey matter volume via MRI scanning, assessing levels of anxiety using Beck Anxiety Inventory (BAI), and establishing an oral version of the Digit Symbol Substitution Test (SDMT)."
Is the elderly population being considered for this research endeavor?
"This clinical trial is accepting geriatric participants that are over 50 years of age but not exceeding 80 years."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger